Eli Lilly Archives - Express Pharma

NICE rejects second Alzheimer’s drug but opportunity remains for decision change: GlobalData

Ebglyss FDA approval intensifies competition in atopic dermatitis market: GlobalData

GS1 India hosts healthcare conference on ‘Navigating the Future of Healthcare’

Radiopharmaceuticals for prostate cancer to go nuclear with $6.3 bn in sales by 2030

US FDA approves Eli Lilly’s drug for eczema

Weight-loss market to see 16 new drugs by 2029, report estimates

GLP-1R market: A two-horse race, says GlobalData

Organon, Lilly expand migraine commercialisation agreement to 11 additional markets

Obesity drug tirzepatide approval in China strengthens market position amid GLP-1 agonist competition: GlobalData

WHO issues warnings on fake copies of Novo Nordisk’s weight-loss drugs